Precision medicine treatment in older AML: Results of Beat AML master trial

Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-cell therapy

Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse of B-ALL in children and adolescents

CANDOR: Triple drug combo delays disease progression in stubborn multiple myeloma

Maintenance therapy with CC-486 for acute myeloid leukaemia

Daratumuab, carfilzomib and dexamethasone increases survival in patients with relapsed/refractory multiple myeloma

QUAZAR AML-001: Evaluating CC-486 as a maintenance therapy for older patients with acute myeloid leukaemia in first remission

MURANO trial: Venetoclax-rituximab shows sustained benefit in relapsed/refractory chronic lymphocytic leukaemia

Glasdegib in combination with azacitidine in patients with untreated higher-risk myelodysplastic syndromes and AML

Addressing the treatment gap for patients with relapsed/refractory primary systemic AL amyloidosis: TOURMALINE-AL1 trial results

Carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma

Challenges and importance of long-term treatment for newly diagnosed multiple myeloma patients; community-based trial data